Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Letter to the Editor/Reply

The Use of the Chronic Kidney Disease Epidemiology Collaboration Equation and Global Cardiovascular Risk Assessment in Patients with Atrial Fibrillation

Providência R.a, b · Barra S.a · Paiva L.a · Faustino A.a

Author affiliations

aCardiology Department, Coimbra's Hospital Centre and University and bUniversity of Coimbra, Faculty of Medicine, Coimbra, Portugal

Related Articles for ""

Cardiology 2013;124:220-221

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Letter to the Editor/Reply

Received: January 21, 2013
Accepted: January 21, 2013
Published online: March 29, 2013
Issue release date: April 2013

Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0

ISSN: 0008-6312 (Print)
eISSN: 1421-9751 (Online)

For additional information: https://www.karger.com/CRD

Abstract

No abstract available


References

  1. Balta S, Demirkol S, Arslan Z, Sahin MA, Yesil FG, Kucuk U: The relation between decreased glomerular filtration rate and nonvalvular atrial fibrillation. Cardiology 2013;124:219.
  2. Providência R, Fernandes A, Paiva L, Faustino A, Barra S, Botelho A, et al: Decreased glomerular filtration rate and markers of left atrial stasis in patients with non-valvular atrial fibrillation. Cardiology 2013;124:3-10.
  3. Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT: Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 2010;5:1003-1009.
  4. Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B: Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 2010;34:c4249.
    External Resources
  5. Go AS, Fang MC, Udaltsova N, Chang Y, Pomernacki NK, Borowsky L, et al: Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2009;119:1363-1369.
  6. Matsushita K, Tonelli M, Lloyd A, Levey AS, Coresh J, Hemmelgarn BR, et al: Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) study equation for estimated GFR. Am J Kidney Dis 2012;60:241-249.
  7. Piccini JP, Stevens SR, Chang Y, Singer DE, Lokhnygina Y, Go AS, et al: Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF and ATRIA study cohorts. Circulation 2013;127:224-232.
  8. Olesen JB, Lip GY, Kamper AL, Hommel K, Køber L, Lane DA, et al: Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 2012;367:625-635.
  9. Lopez FL, Agarwal SK, Grams ME, Loehr LR, Soliman EZ, Lutsey PL, et al: Relation of serum phosphorus levels to the incidence of atrial fibrillation [from the Atherosclerosis Risk in Communities (ARIC) Study]. Am J Cardiol 2013;111:857-862.
  10. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al: European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012;33:1635-1701.
  11. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al: 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385-1413.

Article / Publication Details

First-Page Preview
Abstract of Letter to the Editor/Reply

Received: January 21, 2013
Accepted: January 21, 2013
Published online: March 29, 2013
Issue release date: April 2013

Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0

ISSN: 0008-6312 (Print)
eISSN: 1421-9751 (Online)

For additional information: https://www.karger.com/CRD


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.